Last reviewed · How we verify
NCT05219071: TRIP-Patch
TRIP-Patch vs the Rigiscan
trial in Erectile Dysfunction in 10 participants. Completed in 14 September 2022.
13 September 2022
Quick facts
| Lead sponsor | St. Antonius Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 10 |
| Start date | 20 June 2022 |
| Primary completion | 13 September 2022 |
| Estimated completion | 14 September 2022 |
| Sites | 1 location across Netherlands |
Conditions studied
- Erectile Dysfunction — all drugs for Erectile Dysfunction →
Sponsor
St. Antonius Hospital
Who can join
Adults 18 to 40, male only, with Erectile Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In men without erectile problems, night time erections occur during the REM-sleep. For this study the current diagnostic test, the Rigiscan is compared, with the data from the TRIP-Patch during the night. To validate discriminating sensor-readings between flaccid state and full rigidity of the penis. Eventually, to have a validated device, a patch in the size of a postage stamp, that easily measures erectile function at home. Furthermore the temperature on the outside of the thigh will be measured.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Shedding light on night-time erections: Determining the feasibility of nocturnal erection detection with penile transdermal light reflection of haemoglobin.
Trip EJ, Torenvlied HJ, Elzevier HW, Pelger RCM, et al · · 2024 · cited 1× · PMID 39323922 · DOI 10.1002/bco2.410
Verify or expand the search:
- PubMed search for NCT05219071
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Erectile Dysfunction
Currently open trials in the same condition.
- NCT07442396 — The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation · NA · recruiting
- NCT07366970 — Is There a Benefit From Addition of Exercise in Diabetic Patients With ED Who Complain Low Vitamin D? · NA · recruiting
- NCT06960746 — Changing Lifestyle in OSA Males Who Suffer Metabolic Syndrome and Impotence: Is There a Response? · NA · recruiting
- NCT06872866 — The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under · Phase 1 · recruiting
- NCT06805513 — Actual Use Trial of Tadalafil 5 mg · Phase 3 · recruiting
Other St. Antonius Hospital trials
Trials by the same sponsor.
- NCT07398118 — CRYO-1: Cryoablation in Elderly Patients With Early-Stage Breast Cancer. · NA · not yet recruiting
- NCT07414446 — Non-Invasive Detection of Pulmonary Right-to-Left Shunts Using the SONAS Ultrasound Device · NA · recruiting
- NCT07309848 — Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs · recruiting
- NCT07157358 — Online Medical Hypnosis Exercises to Improve Mental Health in Primary School Children and Prevent Future Mental Health I · NA · recruiting
- NCT06960174 — Virtual Renality: Assessing the Impact of Virtual Reality on Preoperative Planning in Renal Cancer Surgery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05219071 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by St. Antonius Hospital
- Last refreshed: 21 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05219071.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing